Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed. By Christina Jewett ...
Esperion settles patent litigation with Micro Labs, extending protection for NEXLETOL until April 2040, with ongoing litigation against other defendants. Esperion has reached a settlement with Micro ...
The post The FDA Often Doesn’t Test Generic Drugs for Quality Concerns, So ProPublica Did appeared first on ProPublica.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback